Los Angeles Capital Management LLC Makes New $513,000 Investment in agilon health, inc. (NYSE:AGL)

Los Angeles Capital Management LLC purchased a new stake in agilon health, inc. (NYSE:AGL) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 130,598 shares of the company’s stock, valued at approximately $513,000.

A number of other institutional investors have also made changes to their positions in AGL. J.Safra Asset Management Corp grew its holdings in agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the last quarter. CWM LLC grew its stake in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in agilon health during the second quarter worth $60,000. Bleakley Financial Group LLC acquired a new position in agilon health during the 1st quarter valued at $65,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in agilon health by 17,790.0% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after purchasing an additional 10,674 shares during the period.

Insider Activity at agilon health

In related news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. The trade was a 42.03 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 3.20% of the stock is currently owned by company insiders.

agilon health Stock Performance

NYSE AGL opened at $1.58 on Friday. agilon health, inc. has a 1-year low of $1.58 and a 1-year high of $13.76. The company has a 50 day moving average of $3.05 and a 200-day moving average of $4.85. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $650.99 million, a price-to-earnings ratio of -1.68 and a beta of 0.60.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the firm posted ($0.06) EPS. On average, equities analysts forecast that agilon health, inc. will post -0.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Benchmark reaffirmed a “buy” rating and issued a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Citigroup lowered their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research report on Wednesday. Finally, TD Cowen reduced their target price on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, agilon health presently has an average rating of “Hold” and a consensus target price of $6.38.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.